Top Markets
#1 Black Phoenix Black Phoenix +167.16%
#2 Islamic Coin Islamic Coin +158.10%
#3 Glidr Glidr +84.34%
#4 Acurast Acurast +41.26%
#5 Arowana Arowana +22.44%
#6 Cryptopia Cryptopia +21.67%
#7 FGRS (Figure Tokenized Stock) FGRS (Figure Tokenized Stock) +18.53%
#8 Quantum Resistant Ledger Quantum Resistant Ledger +17.13%
#9 Wrapped Bitcoin (PulseChain) Wrapped Bitcoin (PulseChain) +14.04%
#10 Playnance Playnance +13.05%
Coin of the day
Black Phoenix Black Phoenix
Settings
Language
ENGLISH
Currency
USD
Theme
QSAM Biosciences, Inc. QSAM Biosciences, Inc.

QSAM Biosciences, Inc.

QSAM
Rank in Stocks #41495
Based in Austin, Texas, QSAM Biosciences, Inc. is dedicated to advancing... Based in Austin, Texas, QSAM Biosciences, Inc. is dedicated to advancing nuclear medicine for cancer and related illnesses. A key component of their pipeline is CycloSam (Samarium-153 DOTMP), a radiopharmaceutical currently in clinical development that specifically targets bone. The company holds a licensing agreement with IGL Pharma, Inc. Founded in 2004, the organization operated as Q2Earth, Inc. before rebranding to QSAM Biosciences, Inc. in September 2020.
Share Price
$8.30
Last synced: 2024-05-02
Market Cap
$18.44K
Change (1 day)
7.10%
Change (1 year)
0.00%
Country
US
Trade QSAM Biosciences, Inc. (QSAM)

Category

Healthcare
P/E ratio for QSAM Biosciences, Inc. (QSAM)
P/E ratio as of 2026 TTM: 0
According to QSAM Biosciences, Inc. latest financial reports and stock price the company's current price-to-earnings ratio (TTM) is 0. At the end of 2026 the company had a P/E ratio of 0.
P/E ratio history for QSAM Biosciences, Inc. from 2026 to 2026
P/E ratio at the end of each year
Year P/E Ratio Change
Not enough data for the provided dates.
P/E ratio for similar companies or competitors
Company P/E Ratio P/E Ratio Difference Country
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 28.05 -
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
 31.14 -
NL
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 - -
CH
Samsung Biologics Co.,Ltd. Samsung Biologics Co.,Ltd.
Samsung Biologics Co.,Ltd.
207940.KS
 - -
KR
UCB S.A. UCB S.A.
UCB S.A.
UCB.BR
 19.30 -
BE
How to read a P/E ratio?

The Price/Earnings ratio measures the relationship between a company's stock price and its earnings per share.
A low but positive P/E ratio stands for a company that is generating high earnings compared to its current valuation and might be undervalued. A company with a high negative (near 0) P/E ratio stands for a company that is generating heavy losses compared to its current valuation.

Companies with a P/E ratio over 30 or a negative one are generaly seen as "growth stocks" meaning that investors typically expect the company to grow or to become profitable in the future.

Companies with a positive P/E ratio bellow 10 are generally seen as "value stocks" meaning that the company is already very profitable and unlikely to strong growth in the future.